Veracyte Inc (VCYT) — Cash Flow-to-Debt Ratio
Veracyte Inc (VCYT) has a Cash Flow-to-Debt Ratio of 0.47x as of June 2026, meaning its operating cash flow of $45.83 Million could theoretically repay 0% of its total liabilities ($97.96 Million) in one year. See VCYT FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Veracyte Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Veracyte Inc across 15 annual periods. For the full cash flow conversion analysis, see Veracyte Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Veracyte Inc (2011–2025)
Year-by-year debt coverage analysis for Veracyte Inc. Check Veracyte Inc (VCYT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.41x | $136.31 Million | $96.44 Million | ▲ +133.5% |
| 2024 | 0.61x | $75.10 Million | $124.07 Million | ▼ -3.1% |
| 2023 | 0.62x | $44.22 Million | $70.80 Million | ▲ +573.2% |
| 2022 | 0.09x | $7.54 Million | $81.22 Million | ▲ +126.8% |
| 2021 | -0.35x | $-31.62 Million | $91.31 Million | ▼ -28.1% |
| 2020 | -0.27x | $-9.71 Million | $35.93 Million | ▼ -199.0% |
| 2019 | -0.09x | $-3.23 Million | $35.76 Million | ▲ +72.7% |
| 2018 | -0.33x | $-13.52 Million | $40.88 Million | ▲ +42.7% |
| 2017 | -0.58x | $-23.91 Million | $41.44 Million | ▲ +14.5% |
| 2016 | -0.68x | $-27.98 Million | $41.45 Million | ▲ +39.8% |
| 2015 | -1.12x | $-26.96 Million | $24.03 Million | ▲ +4.7% |
| 2014 | -1.18x | $-27.63 Million | $23.46 Million | ▼ -42.5% |
| 2013 | -0.83x | $-19.16 Million | $23.19 Million | ▼ -63.3% |
| 2012 | -0.51x | $-7.17 Million | $14.17 Million | ▲ +92.8% |
| 2011 | -7.04x | $-13.52 Million | $1.92 Million | — |